This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignees: Bioinfra Inc., Bioinfra Life Science Inc.. Active years: 2013-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013-2020
Title: Ho Sang Shin: Innovator in Cancer Diagnostics
Introduction
Ho Sang Shin is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of cancer diagnostics, holding two patents that focus on innovative methods for diagnosing and monitoring various types of cancer. His work is crucial in advancing medical technology and improving patient outcomes.
Latest Patents
Ho Sang Shin's latest patents include a method for using information on a complex biomarker group to diagnose lung cancer in a subject. This method involves a computing system that acquires a model based on expression level data from individual biomarkers, such as CEA, HE4, ApoA2, TTR, sVCAM-1, and RANTES. The system then determines whether lung cancer is detected by analyzing the acquired data from a biological specimen.
Another significant patent is a method for monitoring, diagnosing, and screening cancer through measuring the concentration of des-R prothrombin activation peptide fragment F2 (des-R F2) in serum. This method specifically targets liver cancer, breast cancer, and stomach cancer by quantifying the expression of des-R F2, a protein marker that is down-regulated in these cancers. This innovative approach allows for effective diagnosis and screening by comparing the expression levels in normal subjects and cancer patients.
Career Highlights
Throughout his career, Ho Sang Shin has worked with notable companies, including Bioinfra Inc. and Bioinfra Life Science Inc. His experience in these organizations has contributed to his expertise in the field of biomedical research and diagnostics.
Collaborations
Ho Sang Shin has collaborated with esteemed colleagues, including Chul Woo Kim and Pil Je Park. These partnerships have fostered a collaborative environment that enhances innovation and research in cancer diagnostics.
Conclusion
Ho Sang Shin is a distinguished inventor whose work in cancer diagnostics is paving the way for more effective detection and treatment methods. His patents reflect a commitment to improving healthcare through innovative technology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile